Gila Therapeutics Inc logo

Gila Therapeutics Inc.

Gila Therapeutics, Inc. focuses on developing therapies for obesity. Its GT-002 is a PYY3-36 agonist that decreases caloric intake, resulting in weight loss.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.gilatherapeutics.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address
1712 Humbolt Avenue South,MN 55403
Minneapolis
United States
Email
Contact Number
+1 612-805-9054

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]